Inactive/Delisted stock

INVO Bioscience Stock (NASDAQ:INVO)


Chart

Previous Close

$0.85

52W Range

$0.63 - $3.50

50D Avg

$0.77

200D Avg

$0.90

Market Cap

$3.25M

Avg Vol (3M)

$1.15M

Beta

1.44

Div Yield

-

INVO Company Profile


INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Show More

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

25

IPO Date

Nov 02, 2020

Website

INVO Performance


Latest Earnings Call Transcripts


Q2 22Aug 15, 22 | 9:41 PM
Q1 22May 16, 22 | 9:19 PM
Q4 21Mar 31, 22 | 10:12 PM

Peer Comparison


TickerCompany
QTTBQ32 Bio Inc.
ONCOOnconetix, Inc.
XYLOXylo Technologies Ltd.
IDRAIdera Pharmaceuticals, Inc.
TickerGate Footer Logo

Tickergate is an advanced stock research & comparison platform for informed data-driven investment decisions. 100% customizable, institutional-grade data, easy to use.

Company

AboutContact

Connect

LinkedIn

©2025 Tickergate

Tickergate does not provide financial advices and does not issue recommendations or offers to buy stocks of sell any securities. Information is provided 'as-is' and solely for informational purposes as an advice. Tickergate does not bear any responsibility or any losses or damages that may occur as a result of reliance on this data.
Start a conversation

Ask me anything about stocks, markets, or financial data.

Market Trends
Compare Stocks